Please provide your email address to receive an email when new articles are posted on . Compared with urine samples, vaginal swabs had significantly greater sensitivity for chlamydia and gonorrhea.

Chlamydia often has no noticeable symptoms. If symptoms do appear, they usually do so between 7–21 days after exposure. Tests can usually detect chlamydia 1–2 weeks after exposure. The time between a ...

At-home STD tests offer convenience and privacy while testing for sexually transmitted diseases (STDs). These diseases are also called sexually transmitted infections (STIs). If you're sexually active ...

Credit: Getty Images. A point-of-care polymerase chain reaction test has high sensitivity and specificity for Chlamydia trachomatis. HealthDay News — A point-of-care (POC) polymerase chain reaction ...

This is a preview. Log in through your library . Abstract Background: Undetected and untreated Chlamydia trachomatis infections can result in a significant health burden. Diagnostic testing refers to ...

The US Food and Drug Administration (FDA) has cleared two tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae from throat and rectum samples. The Aptima Combo 2 Assay (Hologic Inc) and the ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) commends the decision by the United States Centers for Disease Control and Prevention (CDC) to endorse an updated approach to ...

NEW YORK (Reuters Health) - A new 30-minute point-of-care (POC) test using self-collected vaginal swabs works as well as lab-based molecular diagnostic tests for detecting chlamydia and gonorrhea, new ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the FDA has granted clearance for its new Aptima ® BV and Aptima ® CV/TV assays, which provide an accurate and ...

Background: The excellent sensitivity and specificity of commercially available nucleic acid amplification tests (NAATs) for the identification of Neisseria gonorrhoeae have been demonstrated. This ...

(HealthDay)—The U.S. Food and Drug Administration has cleared for marketing two tests that detect the presence of Chlamydia trachomatis and Neisseria gonorrhoeae with diagnostic testing of ...

The FDA has cleared its first at-home test for chlamydia and gonorrhea, the two most common sexually transmitted diseases in the U.S., amid steadily rising numbers of cases. Sold by LetsGetChecked—a ...